 |
市场调查报告书
商品编码
1461442
全球 Barretts 食道市场，依药物类别（质子帮浦抑制剂、H2 受体拮抗剂、黏膜保护剂等）、依配销通路、依地理位置。Global Barretts Esophagus Market, By Drug Class (Proton Pump Inhibitors, H2 Receptor Antagonists, Mucosal Protective Agents, Others), By Distribution Channel, By Geography . |
||||||
预计2024年全球Barrett食道市场价值为50.5亿美元，预计到2031年将达到72亿美元，2024年至2031年年复合成长率(CAGR)为5.2%。
| 报告范围 | 报告详情 | ||
|---|---|---|---|
| 基准年： | 2023年 | 2023/2024 年市场规模： | 50.5 亿美元 |
| 历史数据： | 2019年至2023年 | 预测期： | 2024年至2031年 |
| 预测期间 2023/2024 至 2030/2031 年复合成长率： | 5.20% | 2030/2031 价值预测： | 72亿美元 |
巴雷特食道是一种食道内壁因慢性胃酸逆流而受损的疾病。这是胃食道逆流 (GERD) 的严重併发症，食道内壁被类似肠内壁的异常组织所取代。食道细胞的这种变化会增加食道腺癌（食道癌的一种）的机会。巴雷特食道通常不会引起症状，但可以透过食道胃十二指肠镜检查 (EGD) 和活检来诊断。关键的诱发因素是慢性胃食道逆流症，胃酸多年来会损害食道。其他危险因子包括肥胖、吸烟和男性。这种情况需要密切监测，因为它是食道癌的先兆。治疗包括改变生活方式和药物控制胃酸倒流。在某些情况下，可能会建议射频消融或内视镜黏膜切除术来去除发育不良的组织。
市场动态：
全球巴雷特食道市场的成长是由全球胃食道逆流症 (GERD) 盛行率和肥胖率不断上升所推动的。慢性且未经治疗的胃食道逆流症是巴雷特食道的主要危险因子。根据美国国家糖尿病、消化和肾臟疾病研究所 2020 年发布的报告，大约有 6,000 万美国人每月至少经历一次胃灼热。由于腹部压力过大，肥胖是导致胃食道逆流的另一个重要因素。市场也将从食道癌的常规筛检实践中受益。然而，巴雷特食道的无症状性质可能会限制市场成长，导致某些情况下诊断不足。缺乏批准的治疗药物和高昂的管理费用也在一定程度上对市场构成挑战。然而，从长远来看，正在进行的新型诊断生物标记和治疗策略的研究提供了有利可图的机会。
研究的主要特点：
- 该报告对全球巴雷特食道市场进行了深入分析，并提供了预测期（2024-2031）的市场规模（十亿美元）和年复合成长率（CAGR%），以2023年为基准年。
- 它阐明了不同细分市场的潜在收入成长机会，并解释了该市场有吸引力的投资主张矩阵。
- 这项研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或批准、市场趋势、区域前景以及主要参与者采取的竞争策略的重要见解。
- 它根据以下参数（例如公司亮点、产品组合、主要亮点、财务表现和策略）介绍了全球巴雷特食道市场的主要参与者。
- 本研究涵盖的主要公司包括阿斯特捷利康、武田製药有限公司、辉瑞公司、诺华国际股份公司、赛诺菲、葛兰素史克公司、梯瓦製药工业有限公司、雷迪博士实验室有限公司、太阳製药工业有限公司、 Lupin Limited、AbbVie Inc.、Ferring Pharmaceuticals、Otsuka Pharmaceutical Co., Ltd.、Taiho Pharmaceutical Co., Ltd. 和 Ono Pharmaceutical Co., Ltd.
- 该报告的见解将使行销人员和公司管理当局能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
- 全球巴雷特的食道市场报告迎合了该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进业者和金融分析师。
- 利害关係人可以透过用于分析全球巴雷特食道市场的各种策略矩阵轻鬆做出决策。
目录
第一章：研究目标与假设
- 研究目标
- 假设
第 2 章：市场概述
- 报告说明
- 市场定义和范围
- 执行摘要
第 3 章：市场动态
- 市场动态
- 司机
- 限制
- 机会
- 影响分析
- 害虫分析
- 波特分析
- 技术进步
- 合併、收购和合作场景
- 最近的产品核准
- 监管场景
第 4 章：全球巴雷特食道市场，依药物类别，2019 - 2031 年
- 介绍
- 质子帮浦抑制剂 (PPI)
- H2 受体拮抗剂
- 黏膜保护剂
- 其他（内视镜治疗药物等）
- 市场规模及预测
第 5 章：全球巴雷特食道市场，依配销通路划分，2019 - 2031 年
- 介绍
- 医院药房
- 零售药局
- 网路药局
第 6 章：2019 - 2031 年全球巴雷特食道市场（按地区）
- 介绍
- 北美洲
- 我们
- 加拿大
- 欧洲
- 英国
- 德国
- 义大利
- 法国
- 西班牙
- 俄罗斯
- 欧洲其他地区
- 亚太地区
- 中国
- 印度
- 日本
- 澳洲
- 韩国
- 东协
- 亚太地区其他地区
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
- 中东
- 海湾合作委员会
- 以色列
- 中东其他地区
- 非洲
- 南非
- 北非
- 中非
第 7 章：公司简介 - 全球巴雷特食道市场
- AstraZeneca
- 公司简介
- 产品/服务组合
- 财务绩效
- 最新动态/更新
- 战略概览
- Takeda Pharmaceutical Company Limited
- Pfizer Inc.
- Novartis International AG
- Sanofi
- GlaxoSmithKline plc
- Teva Pharmaceutical Industries Ltd.
- Dr. Reddy's Laboratories Ltd.
- Sun Pharmaceutical Industries Ltd.
- Lupin Limited
- AbbVie Inc.
- Ferring Pharmaceuticals
- Otsuka Pharmaceutical Co., Ltd.
- Taiho Pharmaceutical Co., Ltd.
- Ono Pharmaceutical Co., Ltd.
第 8 章：参考文献与研究方法
- 参考
- 研究方法论
Global Barrett's esophagus market is estimated to be valued at USD 5.05 Bn in 2024 and is expected to reach USD 7.20 Bn by 2031, growing at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2023/2024: | US$ 5.05 Bn |
| Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
| Forecast Period 2023/2024 to 2030/2031 CAGR: | 5.20% | 2030/2031 Value Projection: | US$ 7.20 Bn |
Barrett's esophagus is a condition where the lining of the esophagus is damaged due to chronic acid reflux. It is a serious complication of gastroesophageal reflux disease (GERD) where the lining of the esophagus is replaced by the abnormal tissue similar to the lining of the intestine. This change in the cells of the esophagus can increase the chances of developing esophageal adenocarcinoma, a type of esophageal cancer. Barrett's esophagus usually does not cause symptoms but can be diagnosed by esophagogastroduodenoscopy (EGD) along with biopsy. The key predisposing factor is chronic GERD where stomach acid damages the esophagus over many years. Other risk factors include obesity, smoking, and male gender. The condition needs to be closely monitored as it is a precursor to esophageal cancer. Treatment involves lifestyle modifications and medication to control acid reflux. In some cases, radiofrequency ablation or endoscopic mucosal resection may be recommended to remove dysplastic tissues.
Market Dynamics:
Global Barrett's esophagus market growth is driven by increasing prevalence of gastroesophageal reflux disease (GERD) and obesity rates worldwide. Chronic and untreated GERD are major risk factors for Barrett's esophagus. According to the National Institute of Diabetes and Digestive and Kidney Diseases Report published in 2020, approximately 60 million Americans experience heartburn at least once a month. Obesity is another important factor predisposing to GERD due to excess pressure on the abdomen. The market also stands to benefit from routine screening practices for esophageal cancer. However, the market growth can be restrained by the asymptomatic nature of Barrett's esophagus leading to underdiagnoses in some cases. Lack of approved drugs for the treatment and high cost of management procedures also challenges the market to some extent. Nevertheless, ongoing research on novel diagnostic biomarkers and therapeutic strategies present lucrative opportunities in the long run.
Key Features of the Study:
- This report provides an in-depth analysis of the global Barrett's esophagus market, and provides market size (USD Bn) and compound annual growth rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global Barrett's esophagus market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
- The key companies covered as a part of this study include AstraZeneca, Takeda Pharmaceutical Company Limited, Pfizer Inc., Novartis International AG, Sanofi, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Lupin Limited, AbbVie Inc., Ferring Pharmaceuticals, Otsuka Pharmaceutical Co., Ltd., Taiho Pharmaceutical Co., Ltd., and Ono Pharmaceutical Co., Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global Barrett's esophagus market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Barrett's esophagus market
Detailed Segmentation:
- By Drug Class:
- Proton Pump Inhibitors (PPIs)
- H2 Receptor Antagonists
- Mucosal Protective Agents
- Others (Endoscopic Therapy Drugs, etc.)
- By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- AstraZeneca
- Takeda Pharmaceutical Company Limited
- Pfizer Inc.
- Novartis International AG
- Sanofi
- GlaxoSmithKline plc
- Teva Pharmaceutical Industries Ltd.
- Reddy's Laboratories Ltd.
- Sun Pharmaceutical Industries Ltd.
- Lupin Limited
- AbbVie Inc.
- Ferring Pharmaceuticals
- Otsuka Pharmaceutical Co., Ltd.
- Taiho Pharmaceutical Co., Ltd.
- Ono Pharmaceutical Co., Ltd.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
2. Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drug Class
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Market Scenario - Conservative, Like, Opportunistic
- Market Opportunity Map
3. Market Dynamics
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Pest Analysis
- Porters Analysis
- Technological Advancement
- Merger, Acquisition and Collaboration Scenario
- Recent Product Approvals
- Regulatory Scenario
4. Global Barrett's Esophagus Market, By Drug Class, 2019 - 2031, (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
- Segment Trends
- Proton Pump Inhibitors (PPIs), 2019 - 2031, (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
- H2 Receptor Antagonists, 2019 - 2031, (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
- Mucosal Protective Agents, 2019 - 2031, (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
- Others (Endoscopic Therapy Drugs, etc.), 2019 - 2031, (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
5. Global Barrett's Esophagus Market, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
- Segment Trends
- Hospital Pharmacies, 2019 - 2031, (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
- Retail Pharmacies, 2019 - 2031, (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
- Online Pharmacies, 2019 - 2031, (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
6. Global Barrett's Esophagus Market, By Region, 2019 - 2031, (US$ Billion)
- Introduction
- Market Share Analysis, 2024 - 2031, (US$ Billion)
- Segment Trends
- By Region
- North America
- Introduction
- Market Size and Forecast, By Drug Class, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, By Drug Class, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Drug Class, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, By Drug Class, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, By Drug Class, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
- GCC
- Israel
- Rest of The Middle East
- Africa
- Introduction
- Market Size and Forecast, By Drug Class, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country/Region, 2019 - 2031, (US$ Billion)
- South Africa
- North Africa
- Central Africa
7. Company Profiles - Global Barrett's Esophagus Market
- AstraZeneca*
- Company Overview
- Product/Service Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategic Overview
- Takeda Pharmaceutical Company Limited
- Pfizer Inc.
- Novartis International AG
- Sanofi
- GlaxoSmithKline plc
- Teva Pharmaceutical Industries Ltd.
- Dr. Reddy's Laboratories Ltd.
- Sun Pharmaceutical Industries Ltd.
- Lupin Limited
- AbbVie Inc.
- Ferring Pharmaceuticals
- Otsuka Pharmaceutical Co., Ltd.
- Taiho Pharmaceutical Co., Ltd.
- Ono Pharmaceutical Co., Ltd.
8. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
